Methods: 90 subjects (61% male, mean age 65.7±9.6 years) were enrolled from 12 centers across Germany and The Netherlands from September 2012 to December 2013. Subjects previously implanted with the ICM and have or were suspected to have paroxysmal AF were consented for study inclusion. At least two weeks after ICM implant, subjects wore a Holter monitor for 4 days. The ICM was programmed...